TRV GP Iii, LLC, 10% Owner at Jounce Therapeutics, Inc. (JNCE), sold 3,800,000 shares at $8.38 ($31.8M) on 2021-11-12, disclosed to the SEC on 2021-11-16.
Open-market sale of $31.8M JNCE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.38 | 1,900,000 | $15.9M | 50.0% |
| 2 | $8.38 | 1,900,000 | $15.9M | 50.0% |
| Total | $8.38 avg | 3,800,000 | $31.8M | 100% |